Bronchial Diseases: Clinical Trials

556 trials for Bronchial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

404 completed, 50 terminated, 31 recruiting, 25 unknown. 556 Phase 1, 123 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1556Completed 404, Terminated 50, Recruiting 31, Unknown 25, Withdrawn 19, Active not recruiting 18, Not yet recruiting 8, Suspended 1
Phase 2123Completed 73, Terminated 15, Recruiting 10, Active not recruiting 9, Unknown 7, Withdrawn 7, Not yet recruiting 2

Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases

Trials (filtered) newest first · largest first

All 556 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate Asthma
HXN-1013, Placebo - Health Adults, Asthma
Phase 1Not yet recruitingHelixon Biotechnology (Suzhou) Co., Ltd402026-12-012026-10-28
Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)
Anakinra 100 Mg/0.67 Ml Inj Syringe, Saline Placebo/0.67 Ml Inj Syringe - Asthma (Diagnosis), Persistent Asthma
Phase 1Not yet recruitingUniversity of North Carolina, Chapel Hill602026-11-012026-07-15
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, TVAX-008, Placebo - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingGrand Theravac Life Sciences (Hangzhou) Co., Ltd.1052026-10-312026-10-27
Evaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With Asthma
CHF10136, CHF10136 matched placebo - Asthma, Healthy Volunteers
Phase 1RecruitingChiesi Farmaceutici S.p.A.1202026-10-022026-10-13
A Randomized, Double-Blind, Placebo-Controlled Phase Ib Study of Multiple Ascending Doses of EB070 Injection in Adults With Moderate-to-Severe Asthma
EB070 - Asthma
Phase 1Not yet recruitingBiotech Pharmaceutical Co., Ltd.202026-09-302026-10-21
A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children
1mg /kg VIC-1911 - GVHD (Acute or Chronic)
Phase 1RecruitingShanghai Jiao Tong University School of Medicine92026-09-282026-10-20
A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma
SKB575, Placebo - Asthma (Diagnosis)
Phase 1RecruitingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.362026-08-252026-09-10
A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
AMG 691 - Healthy Participants
Phase 1RecruitingAmgen282026-08-072026-10-28
Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants
Belumosudil - Chronic Graft Versus Host Disease
Phase 1Not yet recruitingSanofi582026-08-062026-07-24
A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
GSK5784283 - Asthma
Phase 1RecruitingGlaxoSmithKline242026-07-172026-07-29
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
AHB-137 injection - Chronic Hepatitis B
Phase 1RecruitingAusper Biopharma Co., Ltd.322026-07-092026-07-29
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
PF-08103402, Placebo, Midazolam - Healthy Volunteer Study, Healthy Adults
Phase 1RecruitingPfizer1332026-06-172026-10-13
First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients
Placebo, CTX-187 - Bronchiectasis Adult, Bronchiectasis With Pseudomonas Aeruginosa Colonization
Phase 1RecruitingCentauri Therapeutics Limited1042026-06-162026-07-16
A Study of CDX-622 in Participants With Mild to Moderate Asthma
CDX-622 - Mild to Moderate Asthma
Phase 1RecruitingCelldex Therapeutics122026-06-012026-07-02
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
EVE-Treg - Graft Versus Host Disease (cGvHD)
Phase 1RecruitingSarah Nikiforow, MD212026-05-292026-10-29
A Phase 1 Study of Cizutamig in IgE Mediated Diseases
Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy
Phase 1WithdrawnCandid Therapeutics2026-04-012026-07-22
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
Budesonide/formoterol fumarate Aerosphere, Budesonide/formoterol fumarate pMDI - Asthma
Phase 1CompletedAstraZeneca162026-03-052026-07-15
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
Belumosudil - Chronic Graft Versus Host Disease
Phase 1RecruitingM.D. Anderson Cancer Center82026-02-092026-08-27
Brain State-dependent PCMS in Chronic Stroke
Brain state-dependent paired corticomotoneuronal stimulation (PCMS) - Stroke
Phase 1 / Phase 2Not yet recruitingUniversity of Texas at Austin452026-01-012024-12-06
ADO-5030 in Bronchoconstriction Challenge, Phase 1b
ADO-5030 - Asthma (Diagnosis)
Phase 1Not yet recruitingAdovate362026-01-012026-01-22

Showing 20 of 556. Sign in to see all of them.

Narrower conditions

Asthma (399)  ·  Bronchiolitis Obliterans Syndrome (95)  ·  Pulmonary Disease, Chronic Obstructive (50)  ·  Hypersensitivity (24)  ·  Lung Diseases (23)  ·  Neoplasms (22)  ·  Bronchial Neoplasms (17)  ·  Lung Neoplasms (17)  ·  Respiratory Tract Diseases (17)  ·  Bronchiectasis (16)  ·  Carcinoma, Non-Small-Cell Lung (16)  ·  Graft vs Host Disease (16)  ·  Respiratory Tract Neoplasms (15)  ·  Thoracic Neoplasms (15)  ·  Neoplasms by Site (13)

Broader conditions

Respiratory Tract Diseases (539)  ·  Lung Diseases (513)  ·  Lung Diseases, Obstructive (512)  ·  Immune System Diseases (494)  ·  Hypersensitivity, Immediate (402)  ·  Respiratory Hypersensitivity (402)  ·  Hypersensitivity (380)  ·  Bronchitis (112)  ·  Pathological Conditions, Signs and Symptoms (107)  ·  Bronchiolitis (101)  ·  Organizing Pneumonia (95)  ·  Bronchiolitis Obliterans (93)  ·  Pathologic Processes (91)  ·  Graft vs Host Disease (79)

Interventions

Budesonide (25)  ·  Fluticasone (16)  ·  montelukast (11)  ·  Charcoal (10)  ·  Formoterol Fumarate (10)  ·  Albuterol (8)  ·  Salmeterol Xinafoate (8)  ·  Budesonide, Formoterol Fumarate Drug Combination (6)  ·  Fluticasone-Salmeterol Drug Combination (6)  ·  Saline Solution (6)  ·  fluticasone furoate (6)  ·  Antigens, Dermatophagoides (5)  ·  Moxifloxacin (5)  ·  Prednisone (5)  ·  3-(3-tert-butylsulfanyl-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropionic acid (4)

Sponsors

GlaxoSmithKline (66)  ·  AstraZeneca (39)  ·  Orion Corporation, Orion Pharma (13)  ·  University of North Carolina, Chapel Hill (12)  ·  Chiesi Farmaceutici S.p.A. (11)  ·  Merck Sharp & Dohme LLC (10)  ·  Amgen (9)  ·  MedImmune LLC (8)  ·  Boehringer Ingelheim (7)  ·  Hoffmann-La Roche (7)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Pfizer (7)  ·  Intech Biopharm Ltd. (6)  ·  Novartis Pharmaceuticals (6)  ·  National Cancer Institute (NCI) (5)

Countries

United States (217)  ·  United Kingdom (102)  ·  Germany (51)  ·  China (47)  ·  Australia (46)  ·  Canada (25)  ·  Spain (17)  ·  Netherlands (15)  ·  South Korea (15)  ·  New Zealand (14)  ·  France (13)  ·  Taiwan (13)  ·  Belgium (11)  ·  Finland (10)  ·  Italy (9)

Top investigators

Michelle Hernandez, MD (5)  ·  Robert Wood, MD (5)  ·  Revolution Medicines, Inc. (4)  ·  Cecil Charles, PhD (3)  ·  Chrysoula Doxani, MD, MSc, PhD (3)  ·  Dave Singh (3)

Results publications

PMID 24184147, PMID 29550052, PMID 32907575, PMID 36184023, PMID 37934000, PMID 40185989, PMID 10048682, PMID 11163535, PMID 11728816, PMID 11815760, PMID 11978924, PMID 1280928, PMID 14757603, PMID 15764724, PMID 16164444, PMID 16186597, PMID 17015575, PMID 1731020, PMID 17717202, PMID 18214942, PMID 18244953, PMID 18595987, PMID 19446146, PMID 19717725, PMID 19750190, PMID 19821718, PMID 19944580, PMID 20100768, PMID 20113991, PMID 20122281, PMID 20976161, PMID 21057005, PMID 21639872, PMID 21729182, PMID 21817948, PMID 22129252, PMID 22487117, PMID 22544892, PMID 22616628, PMID 22734014, PMID 22772084, PMID 22955319, PMID 22989372, PMID 23102735, PMID 23176889, PMID 23706713, PMID 23861248, PMID 23903014, PMID 24093504, PMID 24568613

NIH funding

2016 (11), 2014 (6), 2015 (6), 2019 (6), 2009 (4), 2017 (4), 2018 (3), 2023 (3), R01HL135235 (3), P01AT002620 (2), P01AT002647 (2), P01HL158507 (2), U19AI095261 (2), 2008 (1), KL2TR002346 (1)